Insights On Trial Design
-
Mental Health: 5 Facts About Psychedelics
10/16/2024
As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.
-
Educating Globally Diverse Populations Through Branding & Visuals
10/31/2024
See how this customized educational approach significantly enhanced recruitment and retention efforts, helping to ensure a more inclusive trial for Nonobstructive Hypertrophic Cardiomyopathy (nHCM).
-
Evaluating Adaptive Trials: Do They Align With Your Study's Goals?
4/10/2025
In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.
-
Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy
4/11/2025
Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.
-
Local Considerations When Developing sIRB Reliance Policies
6/17/2024
Delve into the importance of training and educating research staff on the sIRB process, fostering a culture of collaboration, and developing mechanisms for monitoring compliance and managing conflicts.
-
Navigating The Clinical Trial Diversity Maze
5/15/2024
Gain comprehensive insights into diversity action plans in clinical trials through this informative presentation, focusing on the latest FDA guidelines for collecting race and ethnicity data.
-
Putting Participants First To Meet Enrollment Goals
2/21/2024
Increase enrollment and save costs by adopting patient- and site-centered methodologies that empower participants to contribute to groundbreaking clinical research on their own terms.
-
A Comparative Guide To CGTs: Modalities, Landscape, And Logistics
2/29/2024
Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy
-
Rare Disease R&D: Continued Growth Amid Challenges
3/21/2025
The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.
-
Beyond Diversity: Cultural Competence And Humility In Clinical Trials
4/21/2025
Learn practical applications that enhance trust, improve data quality, and create more inclusive, effective research worldwide.